thk-5351 Report issue

Small molecule Imaging Experimental
AACT PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CNc1ccc(-c2ccc3cc(OC[C@H](O)CF)ccc3n2)cn1
  • InChIKey: DLVXFZWSPCOWSN-CQSZACIVSA-N
  • Mol. Mass: 327.36
  • ALogP: 3.05
  • ChEMBL Molecule:
    thk-5351  
More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Imaging: 18-fluorine
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

18f thk-5351 | 18f-thk-5351 | thk-5351

Organizations (6)

Research & Development (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Alzheimer Disease (Phase 2)

Cognition Disorders (Phase 2)

Cognitive Dysfunction (Phase 2)

Depressive Disorder, Major (Phase 2)

Diabetes Mellitus (Phase 2)

Neurodegenerative Diseases (Phase 2)

Neuroinflammatory Diseases (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial Organizations: 6

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue